Quality Control by Photo Documentation for Evaluation of Laparoscopic and Open Colectomy with D3 Resection for Stage II/III Colorectal Cancer: Japan Clinical Oncology Group Study JCOG 0404

被引:27
|
作者
Nakajima, Kentaro [1 ]
Inomata, Masafumi [1 ]
Akagi, Tomonori [1 ]
Etoh, Tsuyoshi [1 ]
Sugihara, Kenichi [2 ]
Watanabe, Masahiko [3 ]
Yamamoto, Seiichiro [4 ]
Katayama, Hiroshi [5 ]
Moriya, Yoshihiro [4 ]
Kitano, Seigo [6 ]
机构
[1] Oita Univ, Fac Med, Dept Gastroenterol & Pediat Surg, Oita 8795593, Japan
[2] Tokyo Med & Dent Univ, Dept Surg Oncol, Tokyo, Japan
[3] Kitasato Univ Hosp, Dept Surg, Sagamihara, Kanagawa, Japan
[4] Natl Canc Ctr, Div Colorectal Surg, Tokyo, Japan
[5] Natl Canc Ctr, Multiinst Clin Trial Support Ctr, JCOG Data Ctr, Tokyo 104, Japan
[6] Oita Univ, Fac Med, Oita 8795593, Japan
关键词
colorectal cancer; laparoscopy; photograph; quality control; surgery; COMPLETE MESOCOLIC EXCISION; RANDOMIZED CONTROLLED-TRIAL; TOTAL MESORECTAL EXCISION; RECTAL-CANCER; COLON-CANCER; SURVIVAL; SURGERY; DISSECTION; MULTICENTER; EXPERIENCE;
D O I
10.1093/jjco/hyu083
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective: The quality of surgery with D3 resection in randomized controlled clinical trial [Japan Clinical Oncology Group study (JCOG0404)] was assessed by evaluation of the photo documentation of both open and laparoscopic surgeries. Methods: A multi-institutional randomized-controlled trial (JCOG0404) was conducted to evaluate open and laparoscopic D3 resection (complete mesocolic excision + ligation and dissection at the root of the main vessels) for Stage II/III colon cancer (UMIN-CTR number C000000105). A total of 1057 (open, 528; laparoscopic, 529) eligible patients were enrolled. For quality control, it was ensured that the surgeries were performed by accredited surgeons, and a central committee reviewed each surgery on the basis of the submitted photographs of the resected field, specimen and skin incision. Results: For right-sided tumors, the rate of D3 resection was 98.5% (131/133) in the open arm and 100% (136/136) in the laparoscopic arm, and for left-sided tumors, they were 97.9% (322/329) and 98.2% (320/326), respectively. Sufficient length of the resected longitudinal margin was ensured in all cases. The skin incisions made in all the cases were,8 cm as defined in the protocol in laparoscopic arm. Conclusions: Completion of high quality surgery with D3 resection was confirmed in JCOG0404 by central peer review of photographs of the surgical procedures in addition to operator regulations. This study suggests that the central review of the photo documentation is one of the important tools to assure a quality control of surgical technique in the Phase III randomized-controlled study.
引用
收藏
页码:799 / 806
页数:8
相关论文
共 50 条
  • [21] A Phase II Trial of Combined Treatment of Endoscopic Mucosal Resection and Chemoradiotherapy for Clinical Stage I Esophageal Carcinoma: Japan Clinical Oncology Group Study JCOG0508
    Kurokawa, Yukinori
    Muto, Manabu
    Minashi, Keiko
    Boku, Narikazu
    Fukuda, Haruhiko
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2009, 39 (10) : 686 - 689
  • [22] Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND)
    Tanaka, Kiyo
    Hanai, Nobuhiro
    Eba, Junko
    Mizusawa, Junki
    Asakage, Takahiro
    Homma, Akihiro
    Kiyota, Naomi
    Fukuda, Haruhiko
    Hayashi, Ryuichi
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (12) : 1105 - 1108
  • [23] Current clinical practice of adjuvant chemotherapy for patients with 'high-risk' Stage II colorectal cancer in Japan: a questionnaire survey in the JCOG Study Group
    Ishiguro, Megumi
    Ueno, Hideki
    Kanemitsu, Yukihide
    Hamaguchi, Tetsuya
    Shida, Dai
    Shimada, Yasuhiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2018, 48 (12) : 1109 - 1112
  • [24] A randomized controlled trial to compare laparoscopic surgery with open surgery for symptomatic, non-curable stage IV colorectal cancer (CRC): First efficacy results from Japan clinical oncology group study JCOG1107
    Akagi, T.
    Inomata, M.
    Kanzaka, R.
    Katayama, H.
    Fukuda, H.
    Shiomi, A.
    Ito, M.
    Watanabe, J.
    Murata, K.
    Hirano, Y.
    Shimomura, M.
    Shunsuke, T.
    Hamaguchi, T.
    Kanemitsu, Y.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S726 - S726
  • [25] Phase II study of laparoscopy-assisted distal gastrectomy with nodal dissection for clinical stage I gastric cancer: Japan clinical oncology group study JCOG0703
    Kurokawa, Yukinori
    Katai, Hitoshi
    Fukuda, Haruhiko
    Sasako, Mitsuru
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2008, 38 (07) : 501 - 503
  • [26] Six-year updated results of Japan Clinical Oncology Group study (JCOG0910): Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine in patients with stage III colorectal cancer
    Hamaguchi, T.
    Shimada, Y.
    Mizusawa, J.
    Kanemitsu, Y.
    Shiomi, A.
    Komori, K.
    Ohue, M.
    Watanabe, J.
    Takiguchi, N.
    Nishizawa, Y.
    Takii, Y.
    Ojima, H.
    Funakoshi, T.
    Kato, T.
    Kobatake, T.
    Yamaguchi, T.
    Takashima, A.
    Katayama, H.
    Fukuda, H.
    ANNALS OF ONCOLOGY, 2020, 31 : S416 - S417
  • [27] Phase I/II trial of chemoradiotherapy concurrent with S-1 and cisplatin in patients with clinical stage II/III esophageal carcinoma: Results of the Japan Clinical Oncology Group study JCOG 0604.
    Tahara, Makoto
    Fuse, Nozomu
    Mizusawa, Junki
    Sato, Akihiro
    Nihei, Keiji
    Kanato, Keisuke
    Kato, Ken
    Yamazaki, Kentaro
    Muro, Kei
    Takaishi, Hiromasa
    Boku, Narikazu
    Ohtsu, Atsushi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (03)
  • [28] A randomized trial comparing mesorectal excision with or without lateral lymph node dissection for clinical stage II, III lower rectal cancer: Primary endpoint analysis of Japan Clinical Oncology Group study JCOG0212.
    Fujita, Shin
    Mizusawa, Junki
    Kanemitsu, Yukihide
    Ito, Masaaki
    Kinugasa, Yusuke
    Komori, Koji
    Ohue, Masayuki
    Ota, Mitsuyoshi
    Akazai, Yoshihiro
    Shiozawa, Manabu
    Yamaguchi, Takashi
    Bandou, Hiroyuki
    Katsumata, Kenji
    Murata, Kohei
    Akagi, Yoshito
    Takiguchi, Nobuhiro
    Saida, Yoshihisa
    Akasu, Takayuki
    Moriya, Yoshihiro
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [29] A Phase III Trial of Paclitaxel plus Carboplatin Versus Paclitaxel plus Cisplatin in Stage IVB, Persistent or Recurrent Cervical Cancer: Gynecologic Cancer Study Group/Japan Clinical Oncology Group Study (JCOG0505)
    Saito, Isamu
    Kitagawa, Ryo
    Fukuda, Haruhiko
    Shibata, Taro
    Katsumata, Noriyuki
    Konishi, Ikuo
    Yoshikawa, Hiroyuki
    Kamura, Toshiharu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (01) : 90 - 93
  • [30] Long-term outcomes of laparoscopic versus open D3 dissection for stage II/III colon cancer: Results of propensity score analyses
    Shida, Dai
    Ochiai, Hiroki
    Tsukamoto, Shunsuke
    Kanemitsu, Yukihide
    EJSO, 2018, 44 (07): : 1025 - 1030